Application of continuous glucose monitoring and automated insulin delivery technologies for pregnant women with type 1, type 2, or gestational diabetes: an international consensus statement
Methodological detailsEndorsed by 24 societies and groups
- Endorsed by 24 societies and groups
Recommendations
As issued by the authors
Continuous glucose monitoring (CGM) during preconception and pregnancy is valued for women with pregestational T1D in reducing pregnancy complications
Automated insulin delivery (AID) systems in women with pregestational T1D to improve glycaemic management during preconception, pregnancy and delivery, and postpartum
Original publication
Application of continuous glucose monitoring and automated insulin delivery technologies for pregnant women with type 1, type 2, or gestational diabetes: an international consensus statement. Lancet Diabetes Endocrinol. Published 17 December 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →